NovoCure
NVCR
NVCR
282 hedge funds and large institutions have $8.15B invested in NovoCure in 2020 Q3 according to their latest regulatory filings, with 66 funds opening new positions, 78 increasing their positions, 98 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
7% more funds holding
Funds holding: 264 → 282 (+18)
3.61% more ownership
Funds ownership: 68.86% → 72.47% (+3.6%)
20% less repeat investments, than reductions
Existing positions increased: 78 | Existing positions reduced: 98
Holders
282
Holding in Top 10
9
Calls
$193M
Puts
$169M
Top Buyers
| 1 | +$524M | |
| 2 | +$187M | |
| 3 | +$148M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$81.6M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$80.7M |
Top Sellers
| 1 | -$114M | |
| 2 | -$112M | |
| 3 | -$61.3M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$53.7M |
| 5 |
DCP
Darsana Capital Partners
New York
|
-$41.7M |